Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdams Regulatory News (ADA)

Share Price Information for Adams (ADA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 5.00
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 3.00 (60.00%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
ADA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Memorandum of Understanding

17 Mar 2008 07:01

DawMed Systems PLC17 March 2008 17 March 2008 DAWMED SYSTEMS PLC ("DawMed" or the "Company") MEMORANDUM OF UNDERSTANDING The Board of DawMed, the AIM listed medical device company which designs,manufactures, sells and services healthcare decontamination equipment andassociated consumables used by NHS Trust hospitals, private hospitals, clinicsand Primary Care practitioners, is pleased to announce the signing of aMemorandum of Understanding between its operating subsidiary, DawMedInternational Limited and Schulke & Mayr GmbH, based in Germany, which is amajor manufacturer and supplier of medical and industrial chemicals and gasesthroughout Northern Europe with particular interest in healthcare markets. Schulke & Mayr is the Germany based subsidiary of its long established ultimateparent company AIR Liquide, a world leader in medical and industrial gases andchemicals, based in France and having a corporate presence in 72 countries sinceits formation in 1902, The Memorandum of Understanding provides for DawMed International Limited("DMI") to supply its "AERclens Chemical" machine, a washer-disinfector ("WD")for flexible endoscopes, to Schulke & Mayr. Schulke & Mayr will resell, install and service the DawMed's AERclens WDdecontamination equipment initially in the healthcare markets of Germany andAustria and will also sell all detergent and disinfectant chemicals directly tothe end users of that equipment. This venture is the result of Dawmed's continuous implementation of its strategyto increase its endeavours in export markets, particularly in, but not limitedto Europe and this Memorandum represents an important step forward for DawMedand a not unimportant first for Schulke & Mayr. Commenting, Executive Chairman, Kevin Gilmore, said: "Today's announcement is afurther meaningful positive for DawMed which may or may not represent the firststage of a potential distributorship agreement with Schulke & Mayr for sales ofDawMed's AERclens decontamination equipment in Northern Europe." Jean-Luc Charlet, Managing Director of Schulke & Mayr GmbH said "We areextremely pleased with this agreement with Dawmed. This cooperation will helpour customers to get a very efficient and very reliable solution to their dailyproblems in the field of instrument disinfection" Enquiries: Kevin M Gilmore Tel: 01608 682244Executive Chairman Mob: 07785 396666 Beaumont Cornish LimitedRoland Cornish Tel: 020 7628 3396 Bishopsgate Communications LimitedDominic Barretto Tel: 020 7562 3350 For further information about the Company's business please visit www.dawmed.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Dec 202310:15 amRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
26th Sep 20234:03 pmRNSHolding(s) in Company
18th Aug 20233:33 pmRNSResult of AGM
16th Aug 20231:04 pmRNSHolding(s) in Company
15th Aug 20233:37 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSFinal Results
9th Mar 20233:47 pmRNSAnnouncement by WANdisco
18th Jan 202312:00 pmRNSHolding(s) in Company
17th Jan 20234:18 pmRNSHolding(s) in Company
24th Nov 20227:00 amRNSHalf-year Report
26th Aug 20223:44 pmRNSResult of AGM
7th Jul 20227:00 amRNSFinal Results
26th Nov 20217:00 amRNSHalf-year Report
26th Aug 202111:29 amRNSResult of AGM
28th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSInvestment in Motif Bio Plc
7th May 202111:33 amRNSHolding(s) in Company
7th May 202111:30 amRNSHolding(s) in Company
7th May 20217:00 amRNSInvestment in Seeing Machines Limited
15th Apr 202112:48 pmRNSResult of Open Offer
26th Mar 20217:00 amRNSPlacing and Open Offer
26th Nov 20207:00 amRNSHalf-year Report
22nd Oct 202010:23 amRNSInvestment Commitment in C4X Discovery Holdings
21st Aug 202012:45 pmRNSResult of AGM
30th Jun 20207:00 amRNSFinal Results
19th Jun 20203:24 pmRNSAssignment of Shareholder Loan Facility
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSInvestment
19th Mar 20203:41 pmRNSStatement re COVID-19
11th Mar 20209:41 amRNSChange of Registered Office
3rd Jan 20207:00 amRNSInvestment
17th Dec 20198:57 amRNSDisposal
28th Nov 20197:00 amRNSHalf-year Report
9th Aug 201911:59 amRNSResult of AGM
3rd Jul 20197:00 amRNSFinal Results
29th Jan 20191:26 pmRNSShareholder Loan
27th Nov 20187:00 amRNSHalf-year Report
10th Aug 20182:01 pmRNSResult of AGM
26th Jun 20187:03 amRNSChange of Currency and AGM Proposals
26th Jun 20187:00 amRNSFinal Results
4th Jun 20189:56 amRNSHolding(s) in Company
4th Jun 20189:48 amRNSHolding(s) in Company
15th Dec 201712:55 pmRNSInvestment
28th Nov 20177:00 amRNSHalf-year Report
27th Nov 20172:07 pmRNSInvestment
6th Oct 201712:28 pmRNSDisposal
11th Sep 20175:06 pmRNSInvestment
8th Sep 20175:04 pmRNSResult of AGM and EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.